Risk factors
Achieve Life Sciences (ACHV) risk factors
Item 1A of every Achieve Life Sciences, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors78 risks12 new10 dropped20 reworded
Achieve Life Sciences faces financial distress with $15.0 million in debt and negative cash flow.
Filed Mar 24, 2026 - FY2024 10-K risk factors76 risks
Achieve Life Sciences relies entirely on a single clinical product candidate, cytisinicline, sourced from a single Bulgarian supplier, Sopharma AD. The company faces significant financial risks, including $10.0 million in debt as of December 31, 2024, and a complete lack of product revenue.
Filed Mar 11, 2025